文献速递细菌感染、耐药与抗菌药物医院感染防控

住院肺炎培养阴性后经验性抗生素降阶梯治疗的实施率与结局

De-escalation of Empiric Antibiotics Following Negative Cultures in Hospitalized Patients With Pneumonia: Rates and Outcomes.
PubMed 文献 · Clin Infect Dis · 2021-01-01

降阶梯与较低的ICU转科、住院时长和费用相关,但各医院降阶梯率差异大(2%-35%)。

要点

  • 培养阴性肺炎患者第4天降阶梯率仅13%。
  • 各医院降阶梯率差异大,最高四分位医院中低风险患者降阶梯率仍<50%。

核心结论

  • 培养阴性的住院肺炎患者中仅少数在第4天降阶梯经验性抗生素,且医院间降阶梯率差异大。
  • 降阶梯与较低的ICU转科、住院时长和费用相关。

研究设计与样本

  • 降阶梯定义为第4天停用两种经验性抗MRSA和抗假单胞菌药物(非喹诺酮类)并继续其他抗生素。

主要发现

  • 医院降阶梯率范围为2%-35%,医院降阶梯率四分位与结局无显著关联。

临床怎么用

  • 对培养阴性的住院肺炎患者,可考虑停用经验性抗MRSA和抗假单胞菌药物以实施降阶梯。
  • 需注意各医院降阶梯实践差异大,遵循指南需显著改变临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For patients at risk for multidrug-resistant organisms, IDSA/ATS guidelines recommend empiric therapy against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas. Following negative cultures, the guidelines recommend antimicrobial de-escalation. We assessed antibiotic de-escalation practices across hospitals and their associations with outcomes in hospitalized patients with pneumonia with negative cultures. METHODS: We included adults admitted with pneumonia in 2010-2015 to 164 US hospitals if they had negative blood and/or respiratory cultures and received both anti-MRSA and antipseudomonal agents other than quinolones. De-escalation was defined as stopping both empiric drugs on day 4 while continuing another antibiotic. Patients were propensity adjusted for de-escalation and compared on in-hospital 14-day mortality, late deterioration (ICU transfer), length-of-stay (LOS), and costs. We also compared adjusted outcomes across hospital de-escalation rate quartiles. RESULTS: Of 14 170 patients, 1924 (13%) had both initial empiric drugs stopped by hospital day 4. Hospital de-escalation rates ranged from 2-35% and hospital de-escalation rate quartile was not significantly associated with outcomes. At hospitals in the top quartile of de-escalation, even among patients at lowest risk for mortality, the de-escalation rates were <50%. In propensity-adjusted analysis, patients with de-escalation had lower odds of subsequent transfer to ICU (adjusted odds ratio, .38; 95% CI, .18-.79), LOS (adjusted ratio of means, .76; .75-.78), and costs (.74; .72-.76). CONCLUSIONS: A minority of eligible patients with pneumonia had antibiotics de-escalated by hospital day 4 following negative cultures and de-escalation rates varied widely between hospitals. To adhere to recent guidelines will require substantial changes in practice.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Deshpande A, Richter SS, Haessler S, et al. De-escalation of Empiric Antibiotics Following Negative Cultures in Hospitalized Patients With Pneumonia: Rates and Outcomes. Clin Infect Dis. 2021. PMID: 32129438. doi:10.1093/cid/ciaa212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。